S&P DJI Announces March 2021 Quarterly Rebalance
Filed with ASX · · 9 pages · English
Earlier from Aroa Biosurgery
- Aroa Half Year Results
- Aroa Biosurgery Secures FDA Clearance for Symphony
- European Approval Received for Myriad
Later from Aroa Biosurgery
- Aroa secures FDA clearance for new product
- Preliminary Final Report
- FY21 Full Year Results Presentation
- Trading Halt
- Aroa Completes $47m Placement and Launches $5m SPP
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery